Stallergenes Greer in brief

Headquartered in London (UK), Stallergenes Greer is fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.

Our commitment

Enable people with allergies to live
normal lives.

Focus on AIT

Rapidly growing numbers of people are affected by the allergens that are found in everyday living. Allergies to pollen, house dust mites, animal hair, food and more put boundaries on the way people live.

Press release

June 19, 2017

First real-world evidence shows long term benefits of sublingual immunotherapy to control allergic rhinitis and potentially prevent allergic asthma

All press releases

Learn more about the full resumption of manufacturing at Stallergenes SAS’ plant. Read More